KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pfizer (PFE) Income from Continuing Operations (2016 - 2026)

Pfizer has reported Income from Continuing Operations over the past 18 years, most recently at 2709000000.0 for Q1 2026.

  • Quarterly Income from Continuing Operations fell 8.91% to 2709000000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 7522000000.0 through Mar 2026, down 29.13% year-over-year, with the annual reading at 7786000000.0 for FY2025, 3.29% down from the prior year.
  • Income from Continuing Operations was 2709000000.0 for Q1 2026 at Pfizer, up from 1640000000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 9877000000.0 in Q3 2022 and troughed at 3349000000.0 in Q4 2023.
  • The 5-year median for Income from Continuing Operations is 2974000000.0 (2025), against an average of 3112933333.33.
  • Year-over-year, Income from Continuing Operations crashed 127.62% in 2023 and then soared 9264.52% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 8645000000.0 in 2022, then plummeted by 138.74% to 3349000000.0 in 2023, then surged by 233.8% to 4481000000.0 in 2024, then crashed by 136.6% to 1640000000.0 in 2025, then surged by 265.18% to 2709000000.0 in 2026.
  • Per Business Quant, the three most recent readings for PFE's Income from Continuing Operations are 2709000000.0 (Q1 2026), 1640000000.0 (Q4 2025), and 3550000000.0 (Q3 2025).